Bone drug may help with breast cancer survival rate
Dec 9, 2011
A new study, which was conducted by researchers at the University of Vienna, discovered that a drug that is used to keep bones strong is also one that can improve the survival rate of those who have breast cancer, according to Fox News.
The drug, Zometa, was originally given to women with breast cancer just to keep their bones strong, but seven years later, the researchers realized that it was also improving their rate of survival, almost as much as chemotherapy, the news source reports.
The researchers also found out that it only works with women who have already gone through menopause. It increases the rate of survival as it fights off the chance of the cancer returning.
According to the American Cancer Society, one in eight women in the U.S. will be diagnosed with breast cancer at some point during her lifetime. Not only is it the second most common form of cancer among women behind skin cancer but it is also the second leading cause of cancer-related death among women, following only lung cancer.